Boehringer Ingelheim Competitors and Similar CompaniesClear all
Daiichi Sankyo's competitors and similar companies include AstraZeneca and Lilly.
 Daiichi Sankyo Daiichi Sankyo (第一三共株式会社) is a company specializing in the research, development, and manufacture of innovative pharmaceutical products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. | |
Founding Date | Founding Date 2005 | Founding Date 1999 | Founding Date 1876 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Braine L'alleud, BE Sao Paulo, BR Toronto, CA Shanghai, CN see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more |
Employees | Employees 18,726 | Employees 94,300 | Employees 47,0009% increase |
Valuation ($) | Valuation ($) 61.7 b | Valuation ($) 2.7 b | Valuation ($) 903.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.9t (FY, 2024) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) |
Cost of goods | Cost of goods ¥415.8b (FY, 2024) | Cost of goods $4.9b (FY, 2025) | Cost of goods $11.1b (FY, 2025) |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit $54.2b (FY, 2025) | Gross profit $54.1b (FY, 2025) |
Net income | Net income ¥295.8b (FY, 2024) | Net income $10.2b (FY, 2025) | Net income $20.6b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 130 (FY, 2021) | Countries 120 (FY, 2021) |
Phase I Trials Products | Phase I Trials Products 16 (FY, 2018) | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2019) |
Phase II Trials Products | Phase II Trials Products 7 (FY, 2018) | Phase II Trials Products N/A | Phase II Trials Products 8 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products 7 (FY, 2018) | Phase III Trials Products N/A | Phase III Trials Products 10 (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyLilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View company